These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8704095)

  • 61. Dorothy Reed and Hodgkin's disease: a reflection after a century.
    Zwitter M; Cohen JR; Barrett A; Robinton ED
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):366-75. PubMed ID: 12023141
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cytokines: their relevance to nutrition.
    Grimble RF
    Eur J Clin Nutr; 1989 Apr; 43(4):217-30. PubMed ID: 2661214
    [No Abstract]   [Full Text] [Related]  

  • 63. The role of tumor necrosis factor in systemic inflammatory responses in primate endotoxemia.
    van der Poll T; Levi M; ten Cate H; van Deventer SJ
    Prog Clin Biol Res; 1994; 388():425-33. PubMed ID: 7831375
    [No Abstract]   [Full Text] [Related]  

  • 64. Hodgkin's cell lines: characteristics and possible pathogenetic implications.
    Diehl V; Burrichter H; Schaadt M; Kirchner HH; Fonatsch C; Stein H; Gerdes J; Heit W; Ziegler A
    Hematol Oncol; 1983; 1(2):139-47. PubMed ID: 6610620
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.
    Larrick JW; Kunkel SL
    Pharm Res; 1988 Mar; 5(3):129-39. PubMed ID: 3072553
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [In vivo studies on the inflammatory cellular reactivity in the oral cavity in patients with Hodgkin's disease].
    Fumagalli G; Carcò FP
    Mondo Odontostomatol; 1968; 10(5):569-72. PubMed ID: 5247337
    [No Abstract]   [Full Text] [Related]  

  • 67. [Role of cellular factors in degenerative osteoarthritis].
    Gu ZY; Wu QL; Wang GY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1993 Mar; 28(2):123-5. PubMed ID: 8222963
    [No Abstract]   [Full Text] [Related]  

  • 68. Paradigm shift for graft-versus-host disease.
    Ferrara JL
    Bone Marrow Transplant; 1994 Aug; 14(2):183-4. PubMed ID: 7994229
    [No Abstract]   [Full Text] [Related]  

  • 69. Tumour necrosis factor. Polypeptide mediator network.
    Old LJ
    Nature; 1987 Mar 26-Apr 1; 326(6111):330-1. PubMed ID: 3494200
    [No Abstract]   [Full Text] [Related]  

  • 70. Paracrine promotion of tumor development by the TNF ligand APRIL in Hodgkin's Disease.
    Schwaller J; Went P; Matthes T; Dirnhofer S; Donze O; Mhawech-Fauceglia P; Myit S; Huard B
    Leukemia; 2007 Jun; 21(6):1324-7. PubMed ID: 17315017
    [No Abstract]   [Full Text] [Related]  

  • 71. Examining the role of inflammatory cytokines in chronic inflammatory bowel disease.
    Lichtman SN; Sartor RB
    J Pediatr Gastroenterol Nutr; 1993 Apr; 16(3):239-40. PubMed ID: 8492248
    [No Abstract]   [Full Text] [Related]  

  • 72. Tumor necrosis, cachexia, shock, and inflammation: a common mediator.
    Beutler B; Cerami A
    Annu Rev Biochem; 1988; 57():505-18. PubMed ID: 3052281
    [No Abstract]   [Full Text] [Related]  

  • 73. Tumor necrosis factor alpha and interleukin-1 alpha increase pain thresholds in the rat.
    Sacerdote P; Bianchi M; Ricciardi-Castagnoli P; Panerai AE
    Ann N Y Acad Sci; 1992 Apr; 650():197-201. PubMed ID: 1605477
    [No Abstract]   [Full Text] [Related]  

  • 74. Exploring the biological mechanisms of thymic stromal lymphopoietin.
    Sonesson A
    Br J Dermatol; 2015 Apr; 172(4):848. PubMed ID: 25827729
    [No Abstract]   [Full Text] [Related]  

  • 75. [Tumor necrosis factor: biologic significance, clinical importance and therapeutic usefulness].
    Bolufer P; Molina R
    Med Clin (Barc); 1990 Sep; 95(7):254-6. PubMed ID: 2283897
    [No Abstract]   [Full Text] [Related]  

  • 76. [Interleukin 1: state-of-the-art in relation to clinical aspects].
    Gina AR
    Pol Tyg Lek; 1988 Sep; 43(37):1201-3. PubMed ID: 3073371
    [No Abstract]   [Full Text] [Related]  

  • 77. Interleukin 1 and the pathogenesis of inflammatory diseases.
    Maury CP
    Acta Med Scand; 1986; 220(4):291-4. PubMed ID: 3541498
    [No Abstract]   [Full Text] [Related]  

  • 78. Hodgkin lymphoma cell lines bind to platelets. Incubation with platelets induces CD15 and P-selectin dependent adhesion of the cell lines to Human Umbilical Vein Endothelial cells (HUVEC).
    Ohana OM; Ozer J; Prinsloo I; Benharroch D; Gopas J
    Cancer Biol Ther; 2015; 16(11):1651-9. PubMed ID: 26418972
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interleukin-1 and tumor necrosis factor-alpha in the Reed-Sternberg cells of Hodgkin's disease. Correlation with clinical and morphological "inflammatory" features.
    Benharroch D; Prinsloo I; Apte RN; Yermiahu T; Geffen DB; Yanai-Inbar I; Gopas J
    Eur Cytokine Netw; 1996; 7(1):51-7. PubMed ID: 8704095
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
    Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
    Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.